phosphoprotein C23

MW 110,000, highly methylated major acidic phosphoprotein in nucleolus of Novikoff hepatoma cells; other nucleolar acidic phospoprotein: B23 with MW 37,000

Also Known As:

Networked: 8 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Hu, Tao: 2 articles (01/2019 - 02/2018)
2.	Huang, Shenghai: 2 articles (01/2019 - 02/2018)
3.	Qiu, Huan: 2 articles (01/2019 - 02/2018)
4.	Wu, Xuan: 2 articles (01/2019 - 02/2018)
5.	Yuan, Xiaoling: 2 articles (01/2019 - 02/2018)
6.	Ceribelli, Angela: 1 article (10/2022)
7.	Hasegawa, Tomoko: 1 article (10/2022)
8.	Satoh, Minoru: 1 article (10/2022)
9.	Tanaka, Shin: 1 article (10/2022)
10.	Lushnikova, A A: 1 article (07/2019)

Related Diseases

1.	Respiratory Syncytial Virus Infections 01/01/2019 - "Our previous study revealed that toll-like receptor 4 (TLR4) and nucleolin (C23) could be modulated and that they played a role during RSV infection in mouse neuronal-2a (N2a) cells. " 02/10/2018 - "In the present study, the infectivity of RSV on N2a neuronal cells and the possible roles of Toll-like receptor 4 (TLR4) and nucleolin (C23) during RSV infection were investigated. "
2.	Rheumatic Diseases (Rheumatism) 10/01/2022 - "Anti-hUBF/NOR90, nucleophosmin/B23, and nucleolin/C23 are known for decades and reported in systemic autoimmune rheumatic diseases (SARDs), malignancies, graft versus host disease (GVHD), and others; however, their clinical significance remains to be established."
3.	Neoplasms (Cancer) 10/01/2022 - "Anti-hUBF/NOR90, nucleophosmin/B23, and nucleolin/C23 are known for decades and reported in systemic autoimmune rheumatic diseases (SARDs), malignancies, graft versus host disease (GVHD), and others; however, their clinical significance remains to be established."
4.	Melanoma (Melanoma, Malignant) 07/01/2019 - "Nucleolin/C23 and nucleophosmin/B23, which constitute altogether ~70% of the nucleolus volume, are promising targets for molecular therapy of melanoma. "
5.	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/01/1995 - "Auto-antibodies to human nucleolin/C23 have been reported in patients with systemic lupus erythematosus and other systemic autoimmune disorders. " 11/01/1995 - "An auto-immune serum from a patient with systemic lupus erythematosus patient was found to contain antibodies against human nucleolin/C23 which recognized amino acids 387-461 of nucleolin/C23."

Related Drugs and Biologics

1.	Toll-Like Receptor 4
2.	Nucleophosmin
3.	Complementary DNA (cDNA)
4.	Messenger RNA (mRNA)
5.	Ribonucleoproteins
6.	Proteins (Proteins, Gene)
7.	Antibodies
8.	Amino Acids

Related Therapies and Procedures

1.	Therapeutics